134 related articles for article (PubMed ID: 36095999)
1. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
[TBL] [Abstract][Full Text] [Related]
2. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
[TBL] [Abstract][Full Text] [Related]
3. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
4. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
[TBL] [Abstract][Full Text] [Related]
6. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.
Brayden D; Creed E; O'Connell A; Leipold H; Agarwal R; Leone-Bay A
Pharm Res; 1997 Dec; 14(12):1772-9. PubMed ID: 9453067
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
Castelli MC; Wong DF; Friedman K; Riley MG
Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
[TBL] [Abstract][Full Text] [Related]
8. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
Li Y; Zhu C
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
[TBL] [Abstract][Full Text] [Related]
9. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
Qi R; Ping QN; Zhao W
Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
[TBL] [Abstract][Full Text] [Related]
10. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
[TBL] [Abstract][Full Text] [Related]
11. Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
Malkov D; Wang HZ; Dinh S; Gomez-Orellana I
Pharm Res; 2002 Aug; 19(8):1180-4. PubMed ID: 12240944
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
Alani AW; Robinson JR
Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats.
Qi R; Ping QN
J Microencapsul; 2004 Feb; 21(1):37-45. PubMed ID: 14718184
[TBL] [Abstract][Full Text] [Related]
15. Orally administered heparin for preventing deep venous thrombosis.
Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC; Money SR
Am J Surg; 1998 Aug; 176(2):176-8. PubMed ID: 9737627
[TBL] [Abstract][Full Text] [Related]
16. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist.
Buckley ST; Bækdal TA; Vegge A; Maarbjerg SJ; Pyke C; Ahnfelt-Rønne J; Madsen KG; Schéele SG; Alanentalo T; Kirk RK; Pedersen BL; Skyggebjerg RB; Benie AJ; Strauss HM; Wahlund PO; Bjerregaard S; Farkas E; Fekete C; Søndergaard FL; Borregaard J; Hartoft-Nielsen ML; Knudsen LB
Sci Transl Med; 2018 Nov; 10(467):. PubMed ID: 30429357
[TBL] [Abstract][Full Text] [Related]
17. Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.
Solis-Herrera C; Kane MP; Triplitt C
Clin Diabetes; 2024; 42(1):74-86. PubMed ID: 38230324
[TBL] [Abstract][Full Text] [Related]
18. Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Gonze MD; Salartash K; Sternbergh WC; Baughman RA; Leone-Bay A; Money SR
Circulation; 2000 Jun; 101(22):2658-61. PubMed ID: 10840020
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.
Baughman RA; Kapoor SC; Agarwal RK; Kisicki J; Catella-Lawson F; FitzGerald GA
Circulation; 1998 Oct; 98(16):1610-5. PubMed ID: 9778325
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C
Twarog C; Fattal E; Noiray M; Illel B; Brayden DJ; Taverna M; Hillaireau H
Int J Pharm; 2022 Oct; 626():122131. PubMed ID: 36028084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]